Тable 5.
Distribution of the examined patients according to the RC
| Diagnosis | RC <1.0 | RC=1.0 | RC >1.0 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of patients (abs. number/%) | Lesion size (mm) [median (95% CI)] | SUVmax [median (95% CI)] | Number of patients (abs. number/%) | Lesion size (mm) [median (95% CI)] | SUVmax [median (95% CI)] | Number of patients (abs. number/%) | Lesion size (mm) [median (95% CI)] | SUVmax [median (95% CI)] | |
| Malignant tumors (n=37) | 28/75.7 | 14.2 (11–17) | 1.5 (1.2–1.9) | 1/2.7 | 26 | 11.6 | 8/21.6 | 23.5 (18.0–29.2) | 6.3 (2.6–20.0) |
| Benign tumors and inflammatory diseases (n=49) | 35/71.4 | 14.5 (12–15) | 1.2 (0.7–1.5) | — | — | — | 14/28.6 | 24 (21–26) | 2.1 (1.5–3.1) |
| Total (n=86) | 63/73.2 | 14.4 (13–15) | 1.8 (1.1–1.5) | 1/1.2 | — | — | 22/25.6 | 24 (21–26) | 2.7 (1.9–5.2) |